• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗地亚10年期间慢性丙型肝炎患者延迟就医的趋势。

Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia.

作者信息

Papic Neven, Radmanic Leona, Dusek Davorka, Kurelac Ivan, Zidovec Lepej Snjezana, Vince Adriana

机构信息

Department of Viral Hepatitis, University Hospital for Infectious Diseases, 10 000 Zagreb, Croatia.

School of Medicine, University of Zagreb, 10 000 Zagreb, Croatia.

出版信息

Infect Dis Rep. 2020 Nov 11;12(3):74-81. doi: 10.3390/idr12030016.

DOI:10.3390/idr12030016
PMID:33187150
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7768519/
Abstract

Late presentation to care is the major obstacle to receiving treatment for chronic hepatitis C (CHC). Our aim was to analyze the prevalence and trends of late presenters (LP) at first consultations in Croatia during a 10-year period. This retrospective cross-sectional study included all adult CHC patients ( = 854) entering specialist medical care at the University Hospital for Infectious Diseases Zagreb between 2009 and 2018. LP was defined as liver stiffness measurement ≥ 9.5 kPa or biopsy METAVIR F ≥ 3. During the study period, mean patients' age increased from 37 to 52 years while HCV genotype distribution changed leading to the replacement of genotype 1b with 1a (g1b 32% to 21%; g1a 19% to 38%). A total of 320 (37.4%) were LP; they were older (47.5, IQR 40.5-57.6), and more commonly infected with g1b (34.1%) and g3 (42.5%). The prevalence of LP significantly increased from 31.9% in 2009 to 46.5% in 2018. Late presentation for care of CHC is increasing in Croatia suggesting a gap of diagnosing strategies in patients over 50 years.

摘要

延迟就医是慢性丙型肝炎(CHC)接受治疗的主要障碍。我们的目的是分析克罗地亚10年间初次就诊时延迟就诊者(LP)的患病率及趋势。这项回顾性横断面研究纳入了2009年至2018年间在萨格勒布大学传染病医院接受专科医疗护理的所有成年CHC患者(n = 854)。LP定义为肝脏硬度测量值≥9.5 kPa或活检METAVIR F≥3。在研究期间,患者的平均年龄从37岁增加到52岁,同时HCV基因型分布发生变化,导致1b型被1a型取代(1b型从32%降至21%;1a型从19%升至38%)。共有320例(37.4%)为LP;他们年龄更大(47.5岁,四分位距40.5 - 57.6岁),更常见感染1b型(34.1%)和3型(42.5%)。LP的患病率从2009年的31.9%显著增加到2018年的46.5%。在克罗地亚,CHC延迟就医的情况正在增加,这表明50岁以上患者的诊断策略存在差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b05/7768519/374546e293bd/idr-12-00016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b05/7768519/df35efb344c5/idr-12-00016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b05/7768519/374546e293bd/idr-12-00016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b05/7768519/df35efb344c5/idr-12-00016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b05/7768519/374546e293bd/idr-12-00016-g002.jpg

相似文献

1
Trends of Late Presentation to Care in Patients with Chronic Hepatitis C during a 10-Year Period in Croatia.克罗地亚10年期间慢性丙型肝炎患者延迟就医的趋势。
Infect Dis Rep. 2020 Nov 11;12(3):74-81. doi: 10.3390/idr12030016.
2
HCV genotypes and age distribution in patients of Vienna and surrounding areas.维也纳及周边地区患者的丙型肝炎病毒基因型和年龄分布。
J Clin Virol. 2001 Jan;20(1-2):41-7. doi: 10.1016/s1386-6532(00)00154-2.
3
Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection.持续病毒学应答可阻止纤维化进展:一项慢性丙型肝炎感染者的长期随访研究。
PLoS One. 2017 Oct 24;12(10):e0185609. doi: 10.1371/journal.pone.0185609. eCollection 2017.
4
Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies.1a 型和 3 型丙型肝炎病毒患者中 NS5A 耐药相关取代的流行情况:对当前治疗策略的影响。
J Med Virol. 2018 Jun;90(6):1094-1098. doi: 10.1002/jmv.25048. Epub 2018 Mar 12.
5
From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.克罗地亚皮肤性病学会史——克罗地亚医学协会及《克罗地亚皮肤性病学学报》重要信息概述
Acta Dermatovenerol Croat. 2018 Dec;26(4):344-348.
6
Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing.通过超深度焦磷酸测序法测定,初治的1a型和1b型丙型肝炎病毒感染患者中低丰度耐药变异体的患病率相似。
PLoS One. 2014 Aug 20;9(8):e105569. doi: 10.1371/journal.pone.0105569. eCollection 2014.
7
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
8
Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.丙型肝炎病毒4型感染老年患者的维生素D水平与细胞凋亡之间的相关性
Clin Interv Aging. 2016 May 4;11:523-33. doi: 10.2147/CIA.S104599. eCollection 2016.
9
Distribution of hepatitis C virus genotypes and subtypes in Croatia: 2008-2015.2008 - 2015年克罗地亚丙型肝炎病毒基因型和亚型的分布情况
Cent Eur J Public Health. 2018 Sep;26(3):159-163. doi: 10.21101/cejph.a5021.
10
Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review.西班牙首次寻求专科治疗的慢性 HBV 和 HCV 患者的晚期就诊:一项为期 2 年的登记回顾研究。
Sci Rep. 2021 Dec 17;11(1):24133. doi: 10.1038/s41598-021-01885-0.

引用本文的文献

1
HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons.中欧消除丙型肝炎病毒,特别强调监狱内的微消除。
Viruses. 2022 Feb 26;14(3):482. doi: 10.3390/v14030482.
2
Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis.丙型肝炎相关肝硬化的新冠肺炎患者的实验室检查资料
J Clin Med. 2022 Jan 27;11(3):652. doi: 10.3390/jcm11030652.
3
Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review.治疗 COVID-19 的小分子临床试验的种族差异:最新全面综述。

本文引用的文献

1
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents.直接作用抗病毒药物治疗的 HCV 患者的肝细胞癌长期风险。
Hepatology. 2020 Jan;71(1):44-55. doi: 10.1002/hep.30823. Epub 2019 Aug 19.
2
Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?直接作用抗病毒疗法的广泛应用是否降低了德国开始丙型肝炎病毒治疗患者的晚期就诊和晚期肝病负担?
J Clin Gastroenterol. 2020 Feb;54(2):192-199. doi: 10.1097/MCG.0000000000001189.
3
Treatment of Elderly Patients with Chronic Hepatitis C: A Retrospective Cohort Study.
Drug Dev Res. 2022 Feb;83(1):16-54. doi: 10.1002/ddr.21895. Epub 2021 Nov 11.
老年慢性丙型肝炎患者的治疗:一项回顾性队列研究。
Acta Clin Croat. 2018 Mar;57(1):61-70. doi: 10.20471/acc.2018.57.01.07.
4
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany.直接抗病毒疗法对德国丙型肝炎相关肝移植需求的影响。
J Hepatol. 2018 Oct;69(4):982-984. doi: 10.1016/j.jhep.2018.07.001. Epub 2018 Aug 6.
5
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.在基层医疗环境中进行肝脏硬度测量可检测到高比例的晚期纤维化,并预测丙型肝炎相关的肝脏事件。
J Hepatol. 2018 Sep;69(3):575-583. doi: 10.1016/j.jhep.2018.04.013. Epub 2018 Apr 28.
6
EASL Recommendations on Treatment of Hepatitis C 2018.2018年欧洲肝脏研究学会丙型肝炎治疗推荐意见
J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9.
7
Late Presentation for Care Among Patients With Chronic Hepatitis C: Prevalence and Risk Factors.慢性丙型肝炎患者延迟就医:患病率及危险因素
Open Forum Infect Dis. 2017 Nov 22;5(1):ofx257. doi: 10.1093/ofid/ofx257. eCollection 2018 Jan.
8
Historical epidemiology of hepatitis C virus in select countries-volume 4.部分国家丙型肝炎病毒的历史流行病学——第4卷
J Viral Hepat. 2017 Oct;24 Suppl 2:8-24. doi: 10.1111/jvh.12762.
9
Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.直接抗病毒药物时代丙型肝炎治疗的障碍
Aliment Pharmacol Ther. 2017 Nov;46(10):992-1000. doi: 10.1111/apt.14328. Epub 2017 Sep 26.
10
Late presentation of chronic viral hepatitis for medical care: a consensus definition.慢性病毒性肝炎延迟就医的医学定义:一项共识定义
BMC Med. 2017 May 3;15(1):92. doi: 10.1186/s12916-017-0856-y.